Welcome to Jarir!
Item 1 of 1
Item 1 of 1
LAP Lambert Academic Publishing
Design
Development and Evaluation of Mucoadhesive Nanoemulsion Drugs
SR 432
Inclusive of VAT
SR26Per Month/24 months
This book is printed on demand and is non-refundable after purchase
Available Formats :
Printed Book
It will be sent to your address
SR432
Incl. VAT
Secure Shopping
Convenient Returns
Genuine & Warranted
Fast Delivery
Or
About this Product
The study aimed to create and assess mucoadhesive nanoemulsion-based drug delivery systems (MNEs) for the effective delivery of antimigraine agents into the central nervous system (CNS). The research investigated three categories of drugs: triptans, beta-blockers, and ACE inhibitors, focusing on their potential to improve therapeutic outcomes for migraine treatment. Drug Selected were Triptans: Sumatriptan, Zolmitriptan, Almotriptan, Beta-Blockers: Propranolol, Timolol, Nadolol, ACE Inhibitors: Captopril, Enalapril, Lisinopril Nanoemulsion FormulationMNEs were prepared using standard nanoemulsion techniques, incorporating mucoadhesive polymers to enhance retention in the nasal cavity.The formulations were evaluated for drug release profiles, mucoadhesive strength, and stability.Results Triptans- Sumatriptan: MNEs showed acumulative drug release of 83.43% after 8 hours.- Zolmitriptan: MNEs exhibited acumulative drug release of 83.63% after 8 hours.- Almotriptan: Demonstrated the highest cumulative drug releaseat89.04% after 8 hours.Overall, MNEs significantly improved drug release for all triptans compared to traditional NEs and plain drug solutions (PDS).
Report an issue with this product.
